32 min
Dr. Ted Love on Coming Out of Retirement and Breaking Racial Barriers The Heroes of Science Podcast®
-
- Business
Coming out of retirement after a longtime, successful career as a researcher, scientist and biopharma executive takes a certain kind of dedication. But that’s what former Global Blood Therapeutics’ CEO Dr. Ted Love did. His decision has helped people around the world who are suffering from sickle cell disease.
But most people don’t know that Ted comes from a humble farming background in Alabama. Inspired by his childhood physician, Ted went on to reach the highest levels in his field and help break down some of the barriers facing people of color in this industry. Last year, Global Blood Therapeutics was acquired by Pfizer for $5.4 billion.
Coming out of retirement after a longtime, successful career as a researcher, scientist and biopharma executive takes a certain kind of dedication. But that’s what former Global Blood Therapeutics’ CEO Dr. Ted Love did. His decision has helped people around the world who are suffering from sickle cell disease.
But most people don’t know that Ted comes from a humble farming background in Alabama. Inspired by his childhood physician, Ted went on to reach the highest levels in his field and help break down some of the barriers facing people of color in this industry. Last year, Global Blood Therapeutics was acquired by Pfizer for $5.4 billion.
32 min